After one cycle, the tumor showed a trend toward shrinkage; however, the patient’s performance status declined, precluding further immediate chemotherapy.
← all excerpts
Primary gastric EBV-positive cytotoxic-molecule-negative T-cell lymphoma with TET2 multihit mutations: a case report.
1
—
—